首页> 外国专利> The use of inhibitors of the sodium-hydrogen exchanger such as a benzoylguanidine in the production of a pharmaceutical for the treatment of diseases caused by protozoa

The use of inhibitors of the sodium-hydrogen exchanger such as a benzoylguanidine in the production of a pharmaceutical for the treatment of diseases caused by protozoa

机译:钠氢交换剂的抑制剂,例如苯甲酰基胍,在生产用于治疗由原生动物引起的疾病的药物中的用途

摘要

A Na+/H+ exchanger inhibitor is used in the manufacture of a medicament for the treatment or prophylaxis of disease caused by protozoa such as topical malaria. The Na+/H+ exchanger inhibitor is a substituted benzoyl guanidine, isoquinoline, benzoxazole, benzothiophene, indole, benzimidazole, benzothiazine, benzofuran, indenoyl guanidine, substituted diacylguanidine, isoquinoline acylguanidine, benzothiazine acylguanidine, fluoroalkyl substituted phenylalkyl carboxylic acid guanidide, furan guanidine, thiophene guanidine, pyrrole guanidine, bicyclic heteroaroyl guanidine, substituted phenylalkenyl carboxylic acid guanidide, benzyloxycarbonyl guanidine, fluorophenyl substituted alkenylcarboxylic acid guanidide, cinnamic acid guanidide, sulphonimidamide substituted benzoyl guanidine, biphenyldicarboxylic acid diguanidide, benzenedicarboxylic acid diguanidide, thiophenylalkenylcarboxylic acid guanidide, 1- or 2-naphthoyl guanidine, indanylidineacetyl guanidine, 6-membered N containing heterocyclic guanidine, indoloyl guanidine, guanidine, benzofuran guanidine, benzothiophene guanidine or indolyl guanidine derivative such as: 3-dimethylamino-5-trifluoromethylbenzoylguanidine, 3-phenyl-5-trifluoromethylbenzoylguanidine, 3-isopropyl-4-fluoro-5-trifluoromethylbenzoylguanidine, 3-chloro-5-(1-pyrrolyl)benzoylguanidine, 3-chloro-5-trifluoromethylbenzoylguanidine, 3-dimethylamino-5-(1-pyrrolyl)benzoylguanidine, 3-dimethylamino-4-tert-butylbenzoylguanidine, 4-(3-chloroanilino)-3-methylsulphonylbenzoylguanidine, 4-(4-aminoethylphenoxy)-3-methylsulphonylbenzoylguanidine, 4-(4-aminoethylsulphonylmethylphenoxy)-3-trifluoromethylbenzoylguanidine, 4-(4-aminoethylthiophenoxy)-3-trifluoromethylbenzoylguanidine, 3,5-di-tert-butylbenzoylguanidine, 3,5-di-tert-butyl-4-hydroxybenzoylguanidine, 5-chloro-2-indoloylguanidine, 3,5-dichloro-2-indoloylguanidine, 5-chloro-3-phenylthio-2-indoloylguanidine, 5-chloro-3-phenylsulphonyl-2-indoloylguanidine, 5-methoxy-3-isopropyl-2-indoloylguanidine, 4-benzyloxy-2-indoloylguanidine, 5-chloro-1-(4-picolyl)-2-indoloylguanidine, 2-(4-hydroxyphenyl)-4-benzimidazolylguanidine or N-{3-[3-(3-guanidino-2-methyl-3-oxopropenyl)phenyl]2-methylacryloyl}guanidine.
机译:Na + / H +交换剂抑制剂用于制造药物,该药物用于治疗或预防由原生动物引起的疾病,例如局部疟疾。 Na + / H +交换抑制剂是取代的苯甲酰基胍,异喹啉,苯并恶唑,苯并噻吩,吲哚,苯并咪唑,苯并噻嗪,苯并呋喃,茚基胍,取代的二酰基胍,异喹啉酰基酰基胍,苯并噻嗪酰基胍,氟烷基取代的苯氧烷基苯基,吡咯胍,双环杂芳基胍,取代的苯基链烯基羧酸胍,苄氧羰基胍,氟苯基取代的烯基羧酸胍,肉桂酸胍,亚磺酰胺取代的苯甲酰基胍,联苯基二羧酸二胍,苯二甲酸二胍基二硫代吡啶基或二硫代吡啶基胍,茚满二胍乙酰胍,含六元氮的杂环胍,吲哚基胍,胍,苯并呋喃胍,苯并噻吩胍或吲哚基胍衍生物,例如:3-二甲基氨基-5-三氮杂氟甲基苯甲酰胍,3-苯基-5-三氟甲基苯甲酰胍,3-异丙基-4-氟-5-三氟甲基苯甲酰胍,3-氯-5-(1-吡咯基)苯甲酰胍,3-氯-5-三氟甲基苯甲酰胍,3-二甲基氨基-5-( 1-吡咯基)苯甲酰基胍,3-二甲基氨基-4-叔丁基苯甲酰基胍,4-(3-氯苯胺基)-3-甲基磺酰基苯甲酰基胍,4-(4-氨基乙基苯氧基)-3-甲基磺酰基苯甲酰基胍,4-(4-氨基乙基磺酰基甲基苯氧基)-3-三氟甲基苯甲酰基胍,4-(4-氨基乙基硫代苯氧基)-3-三氟甲基苯甲酰基胍,3,5-二叔丁基苯甲酰基胍,3,5-二叔丁基-4-羟基苯甲酰基胍,5-氯-2-吲哚基胍,3,5-二氯-2-吲哚基胍,5-氯-3-苯硫基-2-吲哚基胍,5-氯-3-苯基磺酰基-2-吲哚基胍,5-甲氧基-3-异丙基-2-吲哚基胍,4-苄氧基-2-吲哚基胍, 5-氯-1-(4-甲基吡啶基)-2-吲哚基胍,2-(4-羟基苯基)-4-苯并咪唑基胍胍或N- {3- [3-(3-胍基-2-甲基-3-氧代]戊烯基)苯基] 2-甲基丙烯酰基}胍。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号